Vascular cells have limited capacities to activate and differentiate T cells: implications for transplant vascular sclerosis.
Pober
J S
JS
Molecular Cardiobiology Program, Boyer Center for Molecular Medicine, Yale University School of Medicine, New Haven, CT 06510, USA.
Ma
W
W
Biedermann
B
B
Libby
P
P
D000938:Antigen-Presenting Cells / Q000276:immunology / Q000473:pathology; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology* / Q000473:pathology; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology* / Q000473:pathology; D002478:Cells, Cultured; D003324:Coronary Artery Disease / Q000209:etiology / Q000276:immunology* / Q000473:pathology; D003331:Coronary Vessels / Q000166:cytology / Q000276:immunology; D004730:Endothelium, Vascular / Q000166:cytology / Q000276:immunology; D016027:Heart Transplantation / Q000009:adverse effects / Q000276:immunology; D006801:Humans; D007371:Interferon-gamma / Q000096:biosynthesis / Q000276:immunology; D007378:Interleukins / Q000096:biosynthesis / Q000276:immunology; D008285:Major Histocompatibility Complex / Q000502:physiology; D009131:Muscle, Smooth, Vascular / Q000166:cytology / Q000276:immunology
D007378:Interleukins; D007371:Interferon-gamma